These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4263649)

  • 1. Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    J Exp Med; 1972 Nov; 136(5):1043-53. PubMed ID: 4263649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.
    Bradlow HL; Gillette PN; Gallagher TF; Kappas A
    J Exp Med; 1973 Oct; 138(4):754-63. PubMed ID: 4270345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect of steroid hormone metabolism in acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Levere RD; Gallagher TF
    Fed Proc; 1972; 31(4):1293-7. PubMed ID: 4261014
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria.
    Casals G; Marcos J; Pozo ÓJ; Aguilera P; Herrero C; To-Figueras J
    Clin Biochem; 2013 Jun; 46(9):819-24. PubMed ID: 23499585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic porphyrias: new findings on the nature of metabolic defects.
    Meyer UA
    Prog Liver Dis; 1976; 5():280-93. PubMed ID: 775544
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of RNA synthesis in avian liver cell cultures by a 5beta-steroid metabolite during induction of delta-aminolevulinate synthase.
    Incefy GS; Kappas A
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2290-4. PubMed ID: 4526207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts.
    Bonkowsky HL; Tschudy DP; Weinbach EC; Ebert PS; Doherty JM
    J Lab Clin Med; 1975 Jan; 85(1):93-102. PubMed ID: 1141734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxidative phosphorylation in experimental hepatic porphyria].
    Panfil B; Dancewicz A
    Acta Physiol Pol; 1971; 22(6):846-8. PubMed ID: 5152824
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect.
    Felsher BF; Kushner JP
    Semin Hematol; 1977 Apr; 14(2):243-51. PubMed ID: 323986
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic porphyrias. Current concepts.
    Walsh JR
    Postgrad Med; 1977 Aug; 62(2):71-81. PubMed ID: 329249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyrin biosynthesis. Enhancement of the fractional catabolic rate of microsomal haem in chemically induced porphyria.
    Meyer UA; Marver HS
    S Afr Med J; 1971 Sep; ():175-7. PubMed ID: 5150273
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies in porphyria. VIII. Relationship of the 5 alpha-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria.
    Anderson KE; Bradlow HL; Sassa S; Kappas A
    Am J Med; 1979 Apr; 66(4):644-50. PubMed ID: 433969
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoplasmic receptor protein for etiochalanolone in chick embryo liver.
    Lane SE; Gidari AS; Levere RD
    J Biol Chem; 1975 Oct; 250(20):8209-13. PubMed ID: 170283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.